MDS Virtual Congress 2020

September 12-16, 2020. Virtual Congress. www.mdscongress.org

Jump to: View All • a b c d e f g h [i] j k l m n o p q r s t u v w x y z

Identification and characterization of anti-prionic compounds that disassemble Tau prions as a novel therapeutic approach for tauopathies

D. Willbold, T. Altendorf, W. Hoyer, J. Mohrlüder (Jülich, Germany)
Identification and characterization of anti-prionic compounds that disassemble αSyn prions as a novel therapeutic approach for synucleinopathies

D. Willbold, M. Sevenich, W. Hoyer, J. Mohrlüder, A. Willuweit (Jülich, Germany)
Identification and clinical characteristics of Mild Cognitive Impairment in Parkinson’s disease

J. Yang, E. Forbes, D. Pourzinal, K. McMahon, D. Copland, G. Byrne, J. O'Sullivan, L. Mitchell, N. Dissanayaka (Herston, Australia)
Identification and Documentation of Delirium in Parkinson’s Disease

R. Cullinan, S. Richardson, A. Yarnall, D. Burn, L. Allan, R. Lawson (Newcastle-Upon-Tyne, United Kingdom)
Identification of a novel XK mutation in a Chinese patient with McLeod Syndrome

J. Ma, Y.M Liu (Jinan, China)
Identification of Factors that Impact Adherence to OnabotulinumtoxinA Treatment for Spasticity in Post-Stroke and Multiple Sclerosis Patients from ASPIRE

A. Esquenazi, W. Feng, G. Wittenberg, P. Gallien, A. Baricich, K. Fanning, A. Zuzek, G. Francisco, D. Bandari (Elkins Park, PA, USA)
Identification of Parkinson’s disease predisposition genes in high-risk pedigrees

P. Moretti, K. Figueroa, S. Pulst, L. Cannon-Albright (Salt Lake City, UT, USA)
Identifying biomarkers to predict disease progression in early stage Parkinson’s disease patients

L. Neilson, J. Baird, B. Lobb, H. Vanderjagt, N. Gray, S. O'Connor, J. Quinn (Portland, OR, USA)
Identifying de novo Parkinson’s disease with optical coherence tomography of the retina: A machine learning classification approach

A. Chrysou, T. Heikka, S. Vander Zee, J. Boertien, N. Jansonius, T. van Laar (Groningen, Netherlands)
Identifying neural signatures of Parkinson’s disease that predict decline in gait and postural control

H. Sigurdsson, A. Yarnall, B. Galna, S. Lord, L. Alcock, R. Morris, R. Lawson, S. Colloby, M. Firbank, N. Pavese, D. Brooks, J. O'brien, D. Burn, L. Rochester (Newcastle upon Tyne, United Kingdom)
Identifying Neuropsychiatric Profiles in Parkinson’s disease, Dementia with Lewy Bodies and Alzheimer’s disease

D. Smith, P. Donaghy, B. Galna, A. Yarnall, J.P Taylor, D. Burn, A. Thomas, L. Rochester, R. Mc Ardle, R. Lawson (Newcastle upon Tyne, United Kingdom)
Identifying the functional brain network of motor reserve in early Parkinson’s disease

S.J Chung, H.R Kim, J.H Jung, P.H Lee, Y. Jeong, Y.H Sohn (Seoul, Republic of Korea)
Idiopathic cervical dystonia – does autoimmunity play a hand?

A. Panwar, N. Sawal, D. Garg, R. Kaur (Chandigarh, India)
Idiopathic Upper Limb Dystonia – Time for a better understanding

T. Ercoli, R. Pellicciari, G. Fabbrini, G. Ferrazzano, MM. Mascia, R. Eleopra, A. Albanese, R. Erro, P. Barone, L. Avanzino, R. Ceravolo, M. Esposito, L. Bertolasi, C. Scaglione, A.R Bentivoglio, M.C Altavista, F. Bono, P. Girlanda, A. Pisani, M.S Cotelli, B. Minafra, A. Castagna, M. Zibetti, S. Misceo, L. Magistrelli, G. Cossu, M. Coletti Moja, A. Berardelli, G. Defazio (Cagliari, Italy)
Impact of Chronotypes and melatonin levels on sleep disorders in patients with Parkinson’s disease

R. Borgohain, M. Voodi, R. Kandadai, S. Meka, T. Syed, S. Turaga (Hyderabad, India)
Impact of community boxing program on motor impairments of Parkinson’s Disease (PD) including: gait, functional mobility, dual task and coordination

S. Shearin, M. Braitsch, R. Querry (Dallas, TX, USA)
Impact of Deep Brain Stimulation on Fall Risk

K. Lyons, V. Pahwa, R. Pahwa (Kansas City, KS, USA)
Impact of dopamine 2/3 receptor agonists on the phenomenology of L-DOPA-induced dyskinesia in patients with Parkinson’s disease

S. Grigoriou, S. Christiansson, P. Odin, M.A Cenci (Lund, Sweden)
Impact of Obstructive Sleep Apnea on Cognitive and Motor Functions in Parkinson’s Disease Patients

M. Elfil, E. Bahbah, M. Eldokmak, M. Attia, B. Koo (New Haven, CT, USA)
Impact of safinamide on non-motor and motor experiences of daily living: Primary results from the prospective, observational ProGo study

S. Isaacson, T. Clinch, E. Farbman, R. Pahwa (Boca Raton, FL, USA)
Impact of STN DBS on a musculoskeletal problem: A case report

S. Zauber (Indianapolis, IN, USA)
Impaired inhibitory control of saccadic eye movements in cervical dystonia: an eye tracking study

F. Carbone, P. Ellmerer, S. Spielberger, P. Mahlknecht, E. Hameter, A. Hussl, A. Hotter, R. Granata, K. Seppi, S. Bösch, W. Poewe, A. Djamshidian (Innsbruck, Austria)
Impaired Structural Connectivity in Parkinson’s Disease and its Neuropsychological Correlates

A. Inguanzo, R. Sala-Llonch, C. Junque, A. Abos, A. Campabadal, C. Uribe, H. Baggio, Y. Compta, M. Marti, F. Valldeoriola, B. Segura (Barcelona, Spain)
Impairment of the mesocortical dopamine system in Parkinson’s disease patients with freezing of gait in a multimodal imaging approach

K. Steidel, M. Ruppert, A. Greuel, I. Palaghia, J. Hammes, T. van Eimeren, L. Timmermann, M. Tittgemeyer, A. Drzezga, C. Eggers (Marburg, Germany)
Impedance Doesn’t Change with Levodopa Treatment

A.Y Yilmaz, C. Akbostanci, A. Savas (Ankara, Turkey)
Implementation of an online, interactive curriculum in movement disorders at nine neurology residency programs

S. Schaefer, Z. London, J. Ferrara, M. McCoyd, C. Cronin, E. Poole Pharr, R. Price, M. Cincotta, H. Rigby, S. Vota, M. Slade, J. Moeller (New Haven, CT, USA)
Implementation of computer game technologies for patients with ataxia due to post-traumatic head injury: Randomized controlled trial

T. Voloshyn, V. Kozyavkin, O. Kachmar (Truskavets, Ukraine)
Implementation of the ParkinsonNet care concept shows better expertise and work satisfaction of health professionals, but improvement of multidisciplinary collaboration takes longer than one year

I. Sturkenboom, M. Nijkrake, H. Woltjer, J. Fritz, A. Kaysen, M. Tiemessen, J. Kalf (Nijmegen, Netherlands)
Implementing a change of approach: From mono- to interdisciplinary follow-up of patients with PD

M. Gjerstad, K. Borch, M. Fredriksen, T. Kirknes, T. Rannstad Haugen, M. Tiemessen, E. Dietrichs, G. Alves (Stavanger, Norway)
Improved Severe Complex Idiopathic Adult Onset Truncal Dystonia with Axial Twisting by Bilateral Pallidal Stimulation: Case Report

A. Shalash, Z. Fayed (Cairo, Egypt)
Improved verb use in Parkinson’s disease following intensive voice treatment

A. Ramage, C. Fox, A. Halpern, L. Ramig (Durham, NH, USA)
Improvement for Gait Disorders in Parkinson’s Disease Through Novel Comprehensive Treatment (IMPROVE study): A Prospective, Open-label, Randomized Controlled Clinical Trial

X. Huang, L. Chen, G. Cai, J. Xin, Y. Yang, Q. Ye (Fuzhou, China)
Improvement in the handicap is maintained after 5 years of deep brain stimulation in Parkinson’s disease

D. Silva, M. Fabbri, L. Guedes, A. Caldas, P. Lobo, B. Cattoni, H. Carvalho, A. Ferreira, M. Rosa, J. Ferreira, M. Coelho (Lisbon, Portugal)
Improving automaticity of walking in Parkinson’s disease: Levodopa or Donepezil?

S. Stuart, R. Morris, A. Giritharan, J. Quinn, J. Nutt, M. Mancini (Newcastle upon Tyne, United Kingdom)
Improving Diagnosis and Treatment of Anxiety in Parkinson’s Disease: IDATA-PD Study Update

N. Dissanayaka, G. Byrne, L. Mitchell, J. O'Sullivan, A. Padmassini, E. White, J. Yang, E. Forbes, K. Thangavelu, T. Au, A. Lehn, R. Adam, N. Pachana (Brisbane, Australia)
Improving estimation of Parkinson’s disease risk – enhancing the PREDICT-PD algorithm

J. Bestwick, S. Auger, D. Grosset, S. Kanavou, G. Giovannoni, A. Lees, J. Cuzick, C. Simonet, R. Rees, D. Rack, M. Jitlal, A. Schrag, A. Noyce (London, United Kingdom)
Improving fall prediction in Parkinson’s disease: A machine-learning-based approach

P. Panyakaew, N. Pornputtapong, R. Bhidayasiri (Bangkok, Thailand)
Improving Hospital Outcomes through the Aware in Care Ambassador Program

A. Wallis, D. Perret (Miami, FL, USA)
Improving person – centered healthcare pathway organization for people with Parkinson’s disease, using Article 51.

S. Bayen, C. Moreau, N. Carrière, JP. Pruvo, M. Bayen, F. Richard, B. Dervaux, L. Defebvre, D. Devos (Lille, France)
Impulse Control Behaviours in People with Parkinson’s Disease: Findings from the Parkinson’s Disease Real-World Impact Assessment (PRISM) Study

A. Antonini, E. Tolosa, J. Ferreira, A. Lees, T. Foltynie, G. Ebersbach, O. Rascol, J.F Rocha, D. Magalhães, P. Soares-da-Silva (Padova, Italy)
Impulse control disorder and ventral striatum dopamine D3 receptor availability in Parkinson’s disease

G. Pagano, S. Molloy, P. Bain, E. Rabiner, K. Chaudhuri, D. Brooks, N. Pavese (Basel, Switzerland)
Impulse control disorder in the patients of Parkinson’s disease: Various correlations

M. Waghralkar, V. Gupta, A. Jukkarwala (Udaipur, India)
Impulse Control Disorders and Other Psychiatric Complications in a Series of Patients Treated Levodopa-Carbidopa Instestinal Gel

A. Contreras, M. Mas, F. Grandas (Madrid, Spain)
Impulse control disorders in Parkinson’s disease: A whole brain morphometric and diffusion tensor study

A. Roux, F. Durif, A. Marques, J. Bonny, B. Pereira (Clermont Ferrand, France)
Impulsive Control Behaviours in Patients with GBA, PARK2 and without Mutations in Genes Associated to Parkinson’s Disease

P. Amami, T. De Santis, B. Garavaglia, A. Albanese (Rozzano, Italy)
Impulsivity and Compulsivity in Cerebellar Ataxias

N. Amokrane, A. Viswanathan, S. Freedman, C. Yang, S. Kuo, C. Lin (New York, NY, USA)
IMU-based study on Gait and Balance in Parkinson´s disease and healthy subjects

J.R Pérez Sánchez, M. González-Sánchez, A. Muñoz González, A. Hernández-Sosa, J. Segura-Buisán, M. Schmid, C. Cermeño, E. Luque Buzo, B. De-La-Casa Fages, A. Contreras Chicote, J.L Pons, D. Torricelli, F. Grandas (Madrid, Spain)
In vivo imaging of presynaptic terminal loss in early Parkinson’s disease

A. Delva, D. Van Weehaeghe, M. Koole, K. Van Laere, W. Vandenberghe (Leuven, Belgium)
In vivo markers of anxiety in drug-naïve Parkinson’s disease

H. Wilson, E. de Natale, M. Politis (London, United Kingdom)
Incidence and survival of psychosis in patients with Parkinson’s Disease (1991-2010)

M. Hajeb, C. Stang, E. Camerucci, T. Turcano, A. Mullan, P. Martin, V. Abler, M. Splett, N. Rashid, J. Bower, M. Mielke, R. Savica (Rochester, MN, USA)
Incidence of essential tremor depending on gender, age and debut of the disease

B. Muminov, R. Matmurodov (Tashkent, Uzbekistan)
Incidence of Hip Fracture in People with Parkinson’s Disease at the Tertiary Care Hospital

M. Ruhullah, K. Shambhaw (Birganj, Nepal)
IncobotulinumtoxinA to treat sialorrhea in Parkinson’s disease: A real-life study

B. Bergmans, V. Schotte, N. Sys, E. Van Massenhove, M. Van Zandijcke (Brugge, Belgium)
Increased attention for food stimuli as a mechanism for weight gain in patients with Parkinson’s disease undergoing DBS of the subthalamic nucleus

J. Steinhardt, H. Hanßen, M. Heldmann, A. Neumann, J. Voges, J. Krauss, V. Tronnier, T. Münte, N. Brüggemann (Lübeck, Germany)
Increased availability of the metabotropic glutamate receptor 5 in the motor system of patients with Parkinson’s disease

C.J Doppler, E. Farrher, C. Régio Brambilla, C.P Filss, J. Lindemeyer, A. Gogishvili, B. Neumaier, M.T Barbe, I. Neuner, C. Lerche, N.J Shah, K.J Langen, G.R Fink, M. Sommerauer (Jülich, Germany)
Increased epinephrine in the saliva of Parkinson’s disease patients: A preliminary observation

P. Wichit, S. Thanprasertsuk, T. Hopetrungraung, O. Phokaewvarangkul, S. Bongsebandhu-phubhakdi, R. Bhidayasiri (Bangkok, Thailand)
Increased expression of conexin 36 in rodent model of Parkinson disease

M. Viegas, L. Santos, F. Scorza, C. Scorza, A. Rodrigues, A. Almeida (SJD, Brazil)
Increased illusory responses in non-hallucinating, cognitively impaired Lewy body disease patients

M. Shahid, A. Rawls, V. Ramirez, S. Ryman, V. Santini, L. Yang, S. Sha, J. Hall, T. Montine, L. Tian, B. Cholerton, V. Henderson, M. Yutsis, K. Poston (Stanford, CA, USA)
Increased neurofilament light chain plasma levels as a biological marker of mild cognitive impairment in Parkinson’s disease

J. Pagonabarraga, R. Perez-Gonzalez, H. Bejr-Kasem, J. Marin-Lahoz, A. Horta-Barba, I. Aracil-Bolaños, F. Sampedro, S. Martinez-Horta, J. Perez-Perez, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)
Increased risk of Parkinson’s disease in patients with schizophrenia spectrum disorders

T. Kuusimäki, H. Al-Abdulrasul, S. Kurki, J. Hietala, S. Hartikainen, M. Koponen, A. Tolppanen, V. Kaasinen (Turku, Finland)
Increased Syllable Duration as a Marker for Dysarthria in Essential Tremor Patients with Deep Brain Stimulation

H. Jergas, J.N Petry-Schmelzer, T. Thies, J. Steffen, H. Dafsari, D. Muecke, V. Visser-Vandewalle, T. Dembek, M. Barbe (Cologne, Germany)
Indication and long-term outcome of device-aided therapies in advanced Parkinson’s disease

M. Shiraishi, F. Maki, M. Kato, Y. Morosawa, I. Takumi, K. Isahaya, N. Sasaki, Y. Hasegawa (Kawasaki, Japan)
Inertial sensor-based kinematics in the differential diagnosis of Parkinson’s disease and atypical parkinsonisms

M. Mendonça, P. Ferreira, R. Barbosa, B. Meira, J. da Silva, R. Costa, R. Matias (Lisboa, Portugal)
Inertial-sensor based full-body kinematics reveals an unstable gait with increased variability in patients with evidence of dopaminergic denervation with 123I-FP-CIT SPECT

M. Mendonça, J. Silva, F. Oliveira, A. Oliveira-Maia, J. Ferreira, D. Costa, R. Costa, R. Matias (Lisboa, Portugal)
Influence of emotion-affective apathy in theory of mind in Parkinson’s disease patients

O. Lucas-Jiménez, N. Ojeda, J. Peña, I. Gabilondo, A. Murueta-Goyena, J.C Gómez-Esteban, R. del Pino, M. Acera, N. Ibarretxe-Bilbao (Bilbao, Spain)
Influencing factors when living with Parkinson’s disease: beyond the disease symptomatology

L. Ambrosio, P. Martinez-Martin, C. Rodriguez-Blazquez, M.C Portillo (Pamplona, Spain)
Information processing components in Parkinson’s disease with and without impulse control disorders: identification of diagnostic and predisposition markers

S.. Cantarero Duque, J.P Romero (Madrid, Spain)
Inhaled levodopa (LD) as a treatment for Parkinson’s disease (PD) patients in an emergency setting

S. Miri, S. Nakano, A. Carwin, M. Anjum, Y. Torres-Yaghi, F. Amjad, F. Pagan (Washington, DC, USA)
Initial Results from the Zambian Epidemiology of Parkinson’s disease and Healthcare Registry (ZEPHyR)

T. Lee, O. Siddiqi, M. Atadzhanov, D. Saylor, J. Fleisher (Aurora, CO, USA)
Inosine 5′-Monophosphate to Raise the Serum Uric Acid Level in Patients with Multiple System Atrophy (IMPROVE-MSA study): A Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Assigned Clinical Trial

J.J Lee, J.H Yoon, S.J Kim, H.S Yoo, S.J Chung, Y.H Lee, S.Y Kang, H.W Shin, S.K Song, J.Y Hong, M.K Sunwoo, J.E Lee, J.S Baik, Y.H Sohn, P.H Lee (Goyang-si, Republic of Korea)
Insomnia may have a mediating role in linking Parkinson’s disease severity to depression and anxiety

G. Yeganyan, S. Khachatryan, Z. Tavadyan (Yerevan, Armenia)
Instrumented Detection of Fluctuations with Wearable Devices in Parkinson’s Disease

G. Rigas, D. Kakalou, N. Tachos, K. Tsamis, N. Kostikis, A. Marcante, R. Di Mitri, M. Di Pumpo, S. Konitsiotis, D. Fotiadis (Ioannina, Greece)
Intact organization of tactile space in isolated focal dystonia

T. Mainka, E. Azanon Gracia, K. Zeuner, A. Knutzen, T. Bäumer, J. Neumann, A. Kühn, M. Longo, C. Ganos (Berlin, Germany)
Inter-network connectivity dynamics underlie compensatory mechanisms in prodromal Parkinson’s disease

A. Droby, N. Omer, M. Artzi, D. Ban-Bashat, M. Hutchison, J. Cederbaum, N. Giladi, A. Mirelman, A. Thaler (Tel Aviv, Israel)
Inter-relation between hand functioning, cognition and quality of life of CP children: 2-year prospective randomized study

T. Voloshyn, V. Kozyavkin, L. Shestopalova (Truskavets, Ukraine)
Interaction between genetic variants and serum levels of organochlorine pesticides contributes to Parkinson’s disease

S.Q Xu, X.D Yang, Y.W Qian, Q. Xiao (Shanghai, China)
Interest of multiplex ligation-dependent probe amplification assay to identify pathogenic mutations in Parkinson’s disease patients

E. Mutez, M. Swiderski, L. Defebvre, M.C Chartier-Harlin, V. Huin (Lille, France)
Interim Analysis of Electrode Position and Motor Outcomes at 6 Months in STN-DBS for Parkinson’s Disease

S. Kolpakwar, A. Rajesh, R. Kandadai, M. Vijayasaradhi, B. Rupam (Hyderabad, India)
Interpretation of health-related quality of life outcomes from the EARLYSTIM Study

P. Martinez-Martin, G. Deuschl, L. Tonder, A. Schnitzler, J.L Houeto, J. Rau, C. Schade-Brittinger, V. Stoker, M. Vidailhet, P. Krack (Madrid, Spain)
Interrater Agreement for Movement Disorder Classification in Children with Mixed Movement Disorders

M. Masten, J. Vermilion, S. Dean, R. Pourdeyhimi, J. Mink, S. Yilmaz (Izmir, Turkey)
Intestinal Methanogen Overgrowth (IMO) More Prevalent than SIBO in Parkinson’s disease with Constipation: Preliminary Results

A. Sharma, Y. Yan, T. Karunaratne, A. Eubanks, J. Kurek, J. Morgan, S. Rao (Augusta, GA, USA)
Intestinal transit in early-moderate Parkinson’s disease correlates with probable RBD – subclinical esophageal dysmotility does not correlate

C. Skjærbæk, K. Knudsen, P. Borghammer (Aarhus, Denmark)
Intracranial Tuberculous Abcess with Acute Parkinsonism: Unusual Finding

KK. Shahedah, A.A Nurul Asyikin (Kuala Lumpur, Malaysia)
Intraoperative test objectively for discovering optimal electrode site for effective imaging (by eye) and bilateral STN-DBS stereotactic functional neurosurgery

V. Rama Raju, L. Neerati, A. Dabbeta, H. Yeruva, S. Konda, N. Guguloth (Hyderabad, India)
Intraparenchymal Cyst Formation and Spontaneous Regression following Deep Brain Stimulation Surgery

A. Boddu, J. Siddiqui (Columbia, MO, USA)
Intrastriatal injection of alpha-synuclein preformed fibrils results in cognitive dysfunction and L-DOPA reversible sensorimotor impairments in rats

S. Fleming, J. Patterson, L. Yan, C. Kemp, K. Miller, A. Stoll, M. Duffy, D. Herman, J. Lipton, K. Luk, J. Goudreau, C. Sortwell (Rootstown, OH, USA)
Intravenous Immunoglobulin Treatment did not improve Tics in a Patient with Gilles de la Tourette Syndrome and intrathecal Antibody Synthesis

N. Szejko, C. Fremer, K.W Sühs, P. Macul, K.R Müller-Vahl (New Haven, CT, USA)
Intrinsic brain functional connectivity predicts treatment-related motor complications in drug-naive Parkinson’s disease patients

R. De Micco, F. Di Nardo, M. Siciliano, G. Caiazzo, F. Esposito, G. Tedeschi, A. Tessitore (Naples, Italy)
Intrinsic Remodeling of the Fovea is Correlated with Contrast Sensitivity Loss in Parkinson’s Disease

E. Pinkhardt, A. Ding, S. Slotnick, J. Kassubek, A. Ludolph, S. Glazman, I. Selesnick, I. Bodis-Wollner (Ulm, Germany)
Investigating Factors Contributing to Parkinson’s disease-related Cognitive Decline

P. Tipton, N. Bulbul, J. Crook, O. Ross, Z. Wszolek, N. Ertekin-taner (Jacksonville, FL, USA)
Investigating Substantia Nigra Damage using Fully Automated Segmentation of Neuromelanin MRI in Early Parkinson’s Disease

R. Gaurav, R. Valabregue, L. Yahia-Cherif, N. Pyatigorskaya, G. Mangone, E. Biondetti, C. Ewenczyk, M. Hutchison, J.C Corvol, M. Vidailhet, S. Lehéricy (Paris, France)
Iron Imaging as a Diagnostic Tool for Parkinson’s Disease: A Systematic Review and Meta-Analysis

N. Pyatigorskaya, C. Sanz Morere, R. Gaurav, E. Biondetti, R. Valabregue, M. Santin, L. Yahia-Cherif, S. Lehericy (Paris, France)
Is acoustic speech analysis applicable for evaluation of swallowing impairment in patients with Parkinson’s disease (PD)?

N. Madetko, S. Budrewicz (Wrocław, Poland)
Is brain perfusion a differentiating factor between Parkinson’s Disease (PD) and Progressive Supranuclear Palsy – Parkinsonism Predominant (PSP-P)?

P. Alster, D. Koziorowski, L. Królicki, A. Friedman (Warsaw, Poland)
Is Chronotype a biomarker for depression in military Veterans with Parkinson’s disease?

A. Sarwar (Houston, TX, TX, USA)
Is early-onset of levodopa-induced dyskinesia a predictor of GBA mutation? A next-generation sequencing study of young-onset Parkinson’s disease patients in Thailand

S. Thanprasertsuk, P. Phowthongkum, T. Hopetrungraung, C. Poorirerngpoom, T. Satirapatya, P. Wichit, O. Phokaewvarangkul, K. Vongpaisarnsin, S. Bongsebandhu-phubhakdi, R. Bhidayasiri (Bangkok, Thailand)
Is it time to consider circulating microRNAs as a diagnostic biomarker in REM sleep behavior disorder?

C. Peralta, D. Giardino, A. Garay, J. Fededa, S. Valiensi, V. Barrachina (Buenos Aires, Argentina)
Is probable REM sleep behavior disorder a risk factor of impulsive-compulsive behaviors in Parkinson’s disease? PPMI study

M.L Fantini, J. Fedler, B. Pereira, D. Weintraub, A. Marques, F. Durif (Clermont Ferrand, France)
Is the Montreal Cognitive Assessment (MoCA) Suitable for Identifying Mild Cognitive Impairment in Parkinson’s Disease?

S. Hassin-Baer, S. Meyer, N. Gemerman, L. Mentzer, S. Israeli-Korn, A. Richardson, V. Livneh, T. Fay Karmon, T. Nevo, H. Strauss, G. Yahalom, S. Rosenblum (Ramat-Gan, Israel)
Item Response Theory Analysis of the MDS-UPDRS Motor Examination: Tremor vs. Non-tremor Items

M. Tosin, C. Goetz, S. Luo, G. Stebbins (Niteroi, Brazil)

Jump to: View All • a b c d e f g h [i] j k l m n o p q r s t u v w x y z